Corteva, Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

Berenberg Bank Keeps Their Hold Rating on Corteva (CTVA)

AI-generated analysis

πŸ“‰ Berenberg Bank maintained a Hold rating on Corteva (CTVA) with a new price target of $78.00.

πŸ’° Corteva's shares closed yesterday at $82.73, above the analyst's price target.

πŸ“Š The current market consensus for CTVA is a Moderate Buy with an average price target of $84.18.

πŸ€– TipRanks recently downgraded its own view on the stock to Hold with an $88.00 price target.

πŸ’Έ Corteva reported quarterly revenue of $3.91 billion for the quarter ending December 31, a slight decline from last year's $3.98 billion.

⚠️ The company posted a GAAP net loss of $552 million compared to a loss of $41 million in the same period last year.

πŸ“‰ Corporate insider sentiment is negative with increased share selling by 69 insiders over the past quarter.

πŸ‘€ VP Brian Titus recently sold 8,311 shares totaling $636,170.16 for the Controller and Principal Accounting Officer role.

πŸ’¬ Other analysts have made recent changes, including Citi raising its price target to $83 and Mizuho to $82.

πŸ“‰ UBS downgraded its view on Corteva from Buy to Neutral in recent market updates.

Bullish Signals
  • Bereneng Bank maintained a Hold rating with a price target of $78.00, indicating sustained analyst interest in the stock.
  • The current analyst consensus remains a Moderate Buy with an average price target of $84.18, suggesting positive market sentiment compared to individual analyst downgrades.
  • Citi raised Corteva's price target to $83 from $80, reflecting continued confidence in the company's outlook.
  • Mizuho also increased its price target for Corteva to $82 from $80, showing a bullish adjustment by another major bank.
  • The article highlights multiple price target increases alongside downgrades, suggesting a mixed but potentially stable investment case.
Risk Factors
  • Bereneg Bank maintains a Hold rating on Corteva (CTVA) with a price target of $78.00, which is below the current stock price of $82.73.
  • The analyst consensus has downgraded to Moderate Buy from an average price target of $84.18 representing only 1.75% upside potential.
  • TipRanks - Anthropic also downgraded the stock to a Hold with a lower price target of $88.00 compared to previous expectations.
  • Corteva reported a quarterly GAAP net loss of $552 million for the quarter ending December 31, a significant deterioration from last year's GAAP net loss of $41 million.
  • Despite current revenue of $3.91 billion, this is down from $3.98 billion reported last year, indicating declining revenue performance.
  • Corporate insider sentiment is negative with an increase in insider selling activity over the past quarter involving 69 insiders.
  • VP Brian Titus sold 8,311 shares worth $636,170.16 last month, signaling reduced confidence from top company officials.
Full Analysis
Bereneg Bank maintained its Hold rating on Corteva (CTVA) yesterday, setting a price target of $78.00 following the company's earnings release for the quarter ending December 31. According to the article, the company reported quarterly revenue of $3.91 billion and a GAAP net loss of $552 million, a significant decrease from last year's figures which showed revenue of $3.98 billion and a GAAP net loss of $41 million. Currently, the analyst consensus on Corteva is a Moderate Buy with an average price target of $84.18, representing 1.75% upside from its share price which closed at $82.73. The analysis highlights mixed market sentiment surrounding Corteva's stock following the earnings report. While Berenberg maintains a Hold rating, TipRanks noted that another analyst firm also downgraded the stock to Hold with an $88.00 price target. Corporate insider activity further reflects negative sentiment on the stock, with 69 insiders showing selling behavior over the past quarter compared to earlier this year. Notably, last month, BRIAN TITUS, the VP, Controller and Principal Accounting Officer of CTVA, sold 8,311 shares for a total value of $636,170.16. The broader analyst landscape presents conflicting outlooks, with several major firms adjusting their positions on Corteva recently. Notable adjustments include Citi raising its price target to $83 from $80, Mizuho increasing its target to $82 from $80, while other institutions moved to downgrade ratings or adjust views. UBS downgraded Corteva from Buy to Neutral, BWG Global changed the view from Positive to Mixed, and Oracle also received upgrades and downgrades from top Wall Street analysts. Despite these conflicting signals, the average price target remains above current trading levels, suggesting moderate bullishness overall despite the Hold rating maintained by Berenberg Bank.